Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30040827HIVENSG00000005844.19protein_codingITGALNoNo3683P20701
TVIS30040828HIVENSG00000005844.19protein_codingITGALNoNo3683P20701
TVIS20007386HPVENSG00000005844.19protein_codingITGALNoNo3683P20701
TVIS20013342HPVENSG00000005844.19protein_codingITGALNoNo3683P20701
TVIS44008681HTLV-1ENSG00000005844.19protein_codingITGALNoNo3683P20701
TVIS44051217HTLV-1ENSG00000005844.19protein_codingITGALNoNo3683P20701
TCGA Plot Options
Drug Information
GeneITGAL
DrugBank IDDB00227
Drug NameLovastatin
Target IDBE0000516
UniProt IDP20701
Regulation Typeinhibitor
PubMed IDs10493852; 11385505; 15822172
CitationsKallen J, Welzenbach K, Ramage P, Geyl D, Kriwacki R, Legge G, Cottens S, Weitz-Schmidt G, Hommel U: Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain. J Mol Biol. 1999 Sep 10;292(1):1-9.@@Weitz-Schmidt G, Welzenbach K, Brinkmann V, Kamata T, Kallen J, Bruns C, Cottens S, Takada Y, Hommel U: Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med. 2001 Jun;7(6):687-92. doi: 10.1038/89058.@@Liao JK, Laufs U: Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2005;45:89-118. doi: 10.1146/annurev.pharmtox.45.120403.095748.
GroupsApproved; Investigational
Direct ClassificationDelta valerolactones
SMILES[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC
PathwaysLovastatin Action Pathway
PharmGKBPA450272
ChEMBLCHEMBL503